No Data
LINE Yahoo, Furukawa Electric, etc. (additional) Rating.
Upgraded - Bullish Code Stock Name Securities Company Previous Change After ------------------------------------------------------------- <4041> Nisso Chemical Daiwa "3" "2" <9531> Tokyo Gas Mizuho "Hold" "Buy" Downgraded - Bearish Code Stock Name Securities Company Previous Change After ------------------------------------------------------------
February 18 [Today's Investment Strategy]
[Fisco Selected Stocks]【Material Commodity】 PEA <4766> 290 yen (2/17) Operates the job information Broadcasting 'Job Post', staffing and recruitment, childcare business ETC. Announced financial results for the fiscal year ending December 2024. Operating profit is 0.067 billion yen (up 12.7% year-on-year). The previous Financial Estimates were 0.1 billion yen. The expansion of the customer base did not proceed as expected. Operating profit for the fiscal year ending December 2025 is expected to be 0.135 billion yen (2.0 times year-on-year). The product competitiveness is supported by collaboration with major job Broadcasting.
List of stock materials from the newspaper, including NTN, Murata Manufacturing, ETC.
*NTN＜6472＞developed a bidirectional rotating fluid Bearing, eliminating the need for a verification process (Nikkan Kogyo, page 1) - ○*Hitachi＜6501＞and 13 other companies collaborated for anti-money laundering measures and executed Asset Trades (Nikkan Kogyo, page 3) - ○*Mitsubishi Corporation＜8058＞and NTT conducted joint verification in AI drug discovery, transmitting large data using IOWN (Nikkan Kogyo, page 4) - ○*Espec＜6859＞launched a testing facility specializing in Battery for Autos, one of the largest in Japan, in Tokoname, Aichi (Nikkan Kogyo, page 8) - ○*IHI＜7013＞original for the Romanian project in the U.S.
Noil Immune --- For the fiscal year ending December 2024, the in-house drug development business and the joint pipeline will continue to be promoted.
Noil Immune Biotech <4893> announced its financial results for the fiscal year ending December 2024 on the 14th. Business revenue was 0.007 billion yen (compared to 0.316 billion yen in the previous term), operating loss was 1.069 billion yen (compared to a loss of 0.775 billion yen in the previous term), recurring loss was 0.962 billion yen (compared to a loss of 1.127 billion yen in the previous term), and net loss for the year was 0.964 billion yen (compared to a loss of 1.13 billion yen in the previous term). As for the company's business status for the fiscal year, the self-developed drug discovery business based on PRIME technology and the joint pipeline will continue.
Focusing on learning conditions and Euglena, SREHD and others seem to be weak.
The U.S. stock market was closed yesterday, February 17, for President's Day. In the major European markets, the UK FTSE 100 was up 0.41%, the German DAX was up 1.26%, and the French CAC 40 was up 0.13%. The exchange rate was 1 dollar = 151.50-60 yen. In today's Tokyo market, Gakujin <2301>, which announced a Share Buyback with a limit of 2.2% of the total outstanding Shares, and JPMC <3276>, which announced a Share Buyback and purchase委託 with a limit of 5.1% of the total outstanding Shares, reported a 7.4% increase in same-store sales for January compared to December.
SREHD, operating profit for Q3 decreased by 4.4% to 1.444 billion yen, announcement of the sale of Stocks.
SREHD <9215> announced its performance for the third quarter of the fiscal year ending March 2025. Revenue increased by 12.6% year-on-year to 14.4 billion 13 million yen, while operating profit decreased by 4.4% to 1.4 billion 44 million yen. Additionally, major Shareholder Sony Group Corp <6758> announced that it would sell Stocks. Approximately 2.11 million 6700 shares, representing about 13% of the total outstanding shares, will be offered in the Overseas market as well. The aim is to improve the floating stock ratio. 【Positive Evaluation】 <9262> Silver Life Revision |